Multiple Sclerosis

Largest, most representative MS premium dataset available for licensing, analytics, and collaboration.

Research-Grade RWD in MS

Disease with no cure

With no cure for MS, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

24,000+*

MS patients in the OM1 PremiOM™ MS Dataset followed prospectively with deep clinical, lab, and other linked data

* Counts complete through Q2 2024

559,000+*

MS patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Specialized Data

 

Why OM1 MS?

 

Sample Use Cases

» Feasibility
» Comparative Effectiveness
» Passive Safety
» Natural History

Publications

Award-Winning Research Team

Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.

Webinar: Using real-world data to amplify disability scores in Multiple Sclerosis patients

View webinar to learn more.

Request a Meeting

  • This field is for validation purposes and should be left unchanged.